- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05244785
Health and Nutrition Survey on Shenzhen Children
May 21, 2022 updated by: Zhou Ji-Chang, Shenzhen Center for Chronic Disease Control
Investigation on Nutritional Health and Growth Status of Primary and Middle School Students in Shenzhen, 2021
- Master and analyze the nutritional health, growth and development status of primary and secondary school students in Shenzhen, and discover the main nutritional health, growth and development problems and influencing factors.
- Provide basic data and evidence-based basis for the municipal government and related departments to formulate child health policies and measures.
Study Overview
Status
Completed
Study Type
Observational
Enrollment (Actual)
4500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guangdong
-
Shenzhen, Guangdong, China, 518020
- Shenzhen Center for Chronic Disease Control
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Primary and secondary school students in Shenzhen.
Description
Inclusion Criteria:
With signed consent to be a study subject.
Exclusion Criteria:
None.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood pressure
Time Frame: 6 months
|
mmHg
|
6 months
|
Weight
Time Frame: 6 months
|
kg
|
6 months
|
Height
Time Frame: 6 months
|
cm
|
6 months
|
Vitamin concentrations in circulation
Time Frame: 8 months
|
measured by EIA, CLIA or LC-MS/MS, nmol/L
|
8 months
|
Mineral concentrations in circulation
Time Frame: 8 months
|
measured by ICP-MS, mass/volume
|
8 months
|
Glucose and lipid concentrations in circulation
Time Frame: 6 months
|
measured by biochemical analyzer, mmol/L
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Jingfan Xiong, Director, Shenzhen Center for Chronic Disease Control
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 20, 2021
Primary Completion (Actual)
February 28, 2022
Study Completion (Actual)
March 31, 2022
Study Registration Dates
First Submitted
October 28, 2021
First Submitted That Met QC Criteria
February 8, 2022
First Posted (Actual)
February 17, 2022
Study Record Updates
Last Update Posted (Actual)
May 24, 2022
Last Update Submitted That Met QC Criteria
May 21, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Child2021
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Growth Disorders
-
Northwell HealthRecruitingGrowth | Growth Disorders | Growth Failure | Growth Hormone TreatmentUnited States
-
University of CopenhagenUniversity of Aarhus; Arla FoodsCompletedGrowth Acceleration | Growth; Stunting, NutritionalDenmark
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Adult Growth Hormone DeficiencyGermany
-
IpsenCompletedGrowth Hormone DisordersUnited Kingdom
-
Cornell UniversityAfrica Future FoundationCompletedMalnutrition | Growth | Stunted Growth | Feeding, ComplementaryEthiopia
-
Novo Nordisk A/SWithdrawnHealthy | Growth Disorder
-
Novo Nordisk A/SCompletedHealthy | Growth DisorderUnited States
-
IpsenCompletedGrowth Disorders | Insulin-Like Growth Factor-1 DeficiencyUnited States
-
Indonesia UniversityWyeth nutrition indonesiaCompletedGrowth; Stunting, NutritionalIndonesia
-
Danone Asia Pacific Holdings Pte, Ltd.KK Women's and Children's HospitalCompletedGrowth; Stunting, NutritionalSingapore